Skip to content
Search for:
Velabs
  • Home
  • About Velabs
    • Mission
    • Team
  • Technology
    • Droplet-based Microfluids
    • Competitive Advantage
      • Fully quantitative fluorescence assays
      • GPCRs
      • Ion Channels
    • Procedures and Products
  • Partnering
    • Pharma Cooperations
    • BD&L Opportunities
    • Services
    • Cooperations
  • Press & Events
  • Jobs
  • Contact
Search for:

Press & Events

Press Releases and Events

  • Velabs and alytas enter into a cooperation for a novel immune-based therapy for obesity (03.09.2019)
  • Velabs and Chiome enter into a Cooperation in GPCR-Specific Functional Antibody Screening (27.08.19)
  • Velabs Secures EUR 3,0 mio in Series B Financing (27.06.19)
  • Velabs and Chiome Bioscience cooperate in GPCR Specific Functional Antibody Screening (24.04.19)
  • Velabs and BioMed X cooperate in Immunology (07.01.19)
  • Accelerating Antibody Discovery (07.03.18)
  • Contact
  • Legal Disclosure
© 2019 Velabs Therapeutics GmbH

Registration

Already have an account?Log in
Sign up

Login

Don't have an account? Click here toSign up
Remember me
Log in